Vote for Proposal 2: Call toll-free at 800-574-6217

Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
06.09.21
OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Proposals Passed
06.09.21
OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars
06.07.21
OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move to New Headquarters in Maryland

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events